# Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck

> **NCT02429089** · PHASE1 · TERMINATED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 21 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck

## Interventions

- **DRUG:** LEE011

## Key facts

- **NCT ID:** NCT02429089
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2017-09-01
- **Final completion:** 2018-09-01
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Decided by the investigator due to the difficulties to recruit
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02429089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02429089, "Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02429089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*